Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 4,304 | 6,396 | N/A |
| Marketable Securities | 158 | N/A | N/A |
| Other current assets | 331 | 1,036 | 0 |
| TOTAL | $4,837 | $7,497 | $N/A |
| Non-Current Assets | |||
| PPE Net | 42 | 73 | N/A |
| Investments And Advances | 0 | 158 | 0 |
| TOTAL | $42 | $231 | $N/A |
| Total Assets | $4,879 | $7,728 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,391 | 851 | 0 |
| Accrued Expenses | 1,013 | 2,272 | N/A |
| Other current liabilities | 966 | 193 | N/A |
| TOTAL | $14,410 | $3,339 | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | N/A | 22 | N/A |
| Other Non-Current Liabilities | 113,939 | 106,876 | 0 |
| TOTAL | $113,939 | $106,876 | $N/A |
| Total Liabilities | $128,349 | $110,215 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | 2 | N/A |
| Retained earnings | -126,471 | -105,488 | N/A |
| TOTAL | $-123,470 | $-102,487 | $N/A |
| Total Liabilities And Equity | $4,879 | $7,728 | $0 |